Doxycycline attenuates acute lung injury following cardiopulmonary bypass: Involvement of matrix metalloproteinases

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 11, 2014, Pages 7460-7468

  Wang, Chang Tian ^a   Zhang, Lei ^a   Wu, Hai Wei ^a   Wei, Lei ^a   Xu, Biao ^a   Li, De Min ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Acute lung injury; Cardiopulmonary bypass; Doxycycline; Matrix metalloproteinases 9; Rat model

Indexed keywords

DOXYCYCLINE; GELATINASE B; INTERLEUKIN 1BETA; MMP9 PROTEIN, RAT; TUMOR NECROSIS FACTOR;

ACUTE LUNG INJURY; ADVERSE EFFECTS; ANIMAL; BRONCHOALVEOLAR LAVAGE FLUID; CARDIOPULMONARY BYPASS; DISEASE MODEL; INFLAMMATION; LUNG; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT;

ACUTE LUNG INJURY; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CARDIOPULMONARY BYPASS; DISEASE MODELS, ANIMAL; DOXYCYCLINE; INFLAMMATION; INTERLEUKIN-1BETA; LUNG; MALE; MATRIX METALLOPROTEINASE 9; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84919479224     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Taggart DP, el-Fiky M, Carter R, Bowman A, Wheatley DJ. Respiratory dysfunction after uncomplicated cardiopulmonary bypass. Ann Thorac Surg 1993; 56: 1123-1128.
2. Apostolakis E, Filos KS, Koletsis E, Dougenis D. Lung dysfunction following cardiopulmonary bypass. J Card Surg 2010; 25: 47-55.
3. Imura H, Caputo M, Lim K, Ochi M, Suleiman MS, Shimizu K, Angelini GD. Pulmonary injury after cardiopulmonary bypass: beneficial effects of low-frequency mechanical ventilation. J Thorac Cardiovasc Surg 2009; 137: 1530-7.
4. Owen CA, Campbell EJ. The cell biology of leukocyte-mediated proteolysis. J Leukoc Biol 1999; 65: 137-50.
5. Hijova E. Matrix metalloproteinases: their biological functions and clinical implications. Bratisl Lek Listy 2005; 106: 127-32.
6. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001; 17: 463-516.
7. Golub LM, Ramamurthy NS, McNamara TF, Greenwald RA, Rifkin BR. Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med 1991; 2: 297-321.
8. Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, Sorsa T. Tetracyclines inhibit connective tissue breakdown by multiple nonantimicrobial mechanisms. Adv Dent Res 1998; 12: 12-26.
9. Mishra A, Bhattacharya P, Paul S, Paul R, Swarnakar S. An alternative therapy for idiopathic pulmonary fibrosis by doxycycline through matrix metalloproteinase inhibition. Lung India 2011; 28: 174-9.
10. Sochor M, Richter S, Schmidt A, Hempel S, Hopt UT, Keck T. Inhibition of Matrix Metalloproteinase-9 with Doxycycline Reduces Pancreatitis-Associated Lung Injury. Digestion 2009; 80: 65-73.
11. Dong GH, Xu B, Wang CT, Qian JJ, Liu H, Huang G, Jing H. A rat model of cardiopulmonary bypass with excellent survival. J Surg Res 2005; 123: 171-5.
12. Steinberg J, Halter J, Schiller HJ, Dasilva M, Landas S, Gatto LA, Maisi P, Sorsa T, Rajamaki M, Lee HM, Nieman GF. Metalloproteinase inhibition reduces lung injury and improves survival after cecal ligation and puncture in rats. J Surg Res 2003; 111: 185-95.
13. Carney DE, Lutz CJ, Picone AL, Gatto LA, Ramamurthy NS, Golub LM, Simon SR, Searles B, Paskanik A, Snyder K, Finck C, Schiller HJ, Nieman GF. Matrix metalloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass. Circulation 1999; 100: 400-6.
14. Wang C, Li D, Qian Y, Wang J, Jing H. Increased matrix metalloproteinase-9 activity and mRNA expression in lung injury following cardiopulmonary bypass. Lab Invest 2012; 92: 910-6.
15. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334-1349.
16. Edmunds LH Jr. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1998; 66: S12-16.
17. Vanlaere I, Libert C. Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock. Clin Microbiol Rev 2009; 22: 224-39.
18. Hamamoto M, Suga M, Nakatani T, Takahashi Y, Sato Y, Inamori S, Yagihara T, Kitamura S. Phosphodiesterase type 4 inhibitor prevents acute lung injury induced by cardiopulmonary bypass in a rat model. Eur J Cardiothorac Surg 2004; 25: 833-8.
19. Calza L, Attard L, Manfredi R, Chiodo F. Doxycycline and chloroquine as treatment for chronic Q fever endocarditis. J Infect 2002; 45: 127-9.
20. Curci JA, Mao D, Bohner DG, Allen BT, Rubin BG, Reilly JM, Sicard GA, Thompson RW. Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms. J Vasc Surg 2000; 31: 325-342.
21. Bendeck MP, Conte M, Zhang M, Nili N, Strauss BH, Farwell SM. Doxcycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury. Am J Pathol 2002; 160: 1089-95.
22. Lee CZ, Xu B, Hashimoto T, McCulloch CE, Yang GY, Young WL. Doxycycline suppresses cerebral matrix metalloproteinase-9 and angiogenesis induced by focal hyperstimulation of vascular endothelial growth factor in a mouse model. Stroke 2004; 35: 1715-1719.
23. Doroszko A, Hurst TS, Polewicz D, Sawicka J, Fert-Bober J, Johnson DH, Sawicki G. Effects of MMP-9 inhibition by doxycycline on proteome of lungs in high tidal volume mechanical ventilation-induced acute lung injury. Proteome Sci 2010; 8: 3.
24. Bretz WA. Low-dose doxycycline plus additional therapies may lower systemic inflammation in postmenopausal women with periodontitis. J Evid Based Dent Pract 2012; 12: 67-8.